You have 9 free searches left this month | for more free features.

FLT

Showing 1 - 25 of 705

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Cancers Trial in Houston (PET Scan, FLT)

Active, not recruiting
  • Advanced Cancers
  • PET Scan
  • FLT
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022

Pancreatic Adenocarcinoma Trial in Dallas (drug, procedure, other)

Completed
  • Pancreatic Adenocarcinoma
  • 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
  • +3 more
  • Dallas, Texas
    UT Southwestern Medical Center
Oct 10, 2022

Brain Tumor Trial in Salt Lake City (Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine)

Recruiting
  • Brain Tumor
  • Multi-tracer PET exams of [18F]FLT and [18F]Fluciclovine
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Oct 6, 2022

Breast Tumor, Metastatic Breast Cancer, Rb+ Breast Cancer Trial in Philadelphia ([18F]FLT, PET/CT, ribociclib)

Active, not recruiting
  • Breast Neoplasm
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Aug 16, 2022

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

Not yet recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • (no location specified)
May 24, 2023

FLT-PET / MRI Brain Mets

Recruiting
  • Brain Metastases
  • Radionecrosis
    • Toronto, Ontario, Canada
      University Health Network
    Oct 6, 2022

    Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Tampa (Gilteritinib, Vyxeos)

    Suspended
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 11, 2022

    Image, Body, Cervix Cancer Trial in Singapore ([18F]FLT-PET/MRI body scan)

    Recruiting
    • Image, Body
    • Cervix Cancer
    • [18F]FLT-PET/MRI body scan
    • Singapore, Singapore
      National Cancer Centre Singapore
    Apr 27, 2022

    Small Cell Lung Cancer Trial in Copenhagen (FLT-PET, MRI)

    Completed
    • Small Cell Lung Cancer
    • FLT-PET
    • MRI
    • Copenhagen, Denmark
      Dept. of Clinical Physiology, Nuclear Medicine and PET, Rigshosp
    May 3, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +5 more
    • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
    • +3 more
    • Los Angeles, California
      USC/Norris Comprehensive Cancer Center
    Jan 31, 2023

    AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

    Not yet recruiting
    • AML, Adult
    • +4 more
    • Amiens, France
    • +19 more
    Sep 1, 2023

    FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia Trial in Wuhan (T cell injection targeting FLT3 chimeric antigen

    Recruiting
    • FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia
    • T cell injection targeting FLT3 chimeric antigen receptor
    • Wuhan, Hubei, China
      Union Hospital, affiliated with TongJi Medical College, HuaZhong
    Jun 20, 2022

    Graft Vs Host Disease Trial in Chapel Hill (Fluorothymidine (FLT))

    Active, not recruiting
    • Graft Vs Host Disease
    • Fluorothymidine (FLT)
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center
    Mar 21, 2022

    The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD

    Recruiting
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Oct 25, 2022

    The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or

    Recruiting
    • Acute Myeloid Leukemia With FLT3/ITD Mutation
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Oct 25, 2022

    Advanced Cancer Trial in Houston (FLT-PET)

    Completed
    • Advanced Cancer
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jan 3, 2022

    AML, Adult Trial in Berne (HDM201, Midostaurin)

    Terminated
    • AML, Adult
    • Berne, Switzerland
      Departement of Medical Oncology, University Hospital Berne
    Oct 3, 2022

    Ewing Sarcoma Trial in United States (drug, diagnostic test, other)

    Recruiting
    • Ewing Sarcoma
    • Trabectedin 1 MG [Yondelis]
    • +3 more
    • Los Angeles, California
    • +5 more
    Aug 15, 2022

    Non Small Cell Lung Cancer, Lung Cancer Trial in Bronx (drug, biological, radiation)

    Recruiting
    • Non Small Cell Lung Cancer
    • Lung Cancer
    • FLT3 Ligand (CDX-301)
    • +2 more
    • Bronx, New York
      Albert Einstein College of Medicine
    Jul 18, 2022

    Acute Myeloid Leukemia Trial in Wuhan (Fludarabine + Cyclophosphamide + TAA05 Cell Injection)

    Recruiting
    • Acute Myeloid Leukemia
    • Fludarabine + Cyclophosphamide + TAA05 Cell Injection
    • Wuhan, Hubei, China
      Wuhan Union Hospital
    Jun 29, 2022

    Acute Myeloid Leukemia Trial in Miami (CPX-351, Midostaurin, Busulfan)

    Recruiting
    • Acute Myeloid Leukemia
    • Miami, Florida
      Miami Cancer Institute at Baptist Health of South Florida
    Jul 27, 2022

    Metastatic Triple Negative Breast Cancer Trial in Dallas (PLD Chemotherapy, CDX-1140, CDX-301)

    Recruiting
    • Metastatic Triple Negative Breast Cancer
    • PLD Chemotherapy
    • +2 more
    • Dallas, Texas
      UT Southwestern Medical Center
    Jun 23, 2022

    Acute Myeloid Leukemia (AML) Trial in United States (Gilteritinib, Ivosidenib, Enasidenib)

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • Basking Ridge, New Jersey
    • +6 more
    Mar 3, 2023

    Leukemia, Acute Myeloid (AML) Trial (Clifutinib, LoDAC, Azacitidine)

    Not yet recruiting
    • Leukemia, Acute Myeloid (AML)
    • (no location specified)
    Oct 16, 2022

    Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Gilteritinib 40 MG Oral Tablet
    • +4 more
    • Lexington, Kentucky
      University of Kentucky
    Oct 27, 2022